Patrick James Orme

Array ( [id] => 7397559 [patent_doc_number] => 20040038921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Composition and method for inhibiting expression of a target gene' [patent_app_type] => new [patent_app_number] => 10/382634 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13823 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038921.pdf [firstpage_image] =>[orig_patent_app_number] => 10382634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470837 [patent_doc_number] => 20040096880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation' [patent_app_type] => new [patent_app_number] => 10/638060 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16833 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096880.pdf [firstpage_image] =>[orig_patent_app_number] => 10638060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033560 [patent_doc_number] => 20050032069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/635380 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33859 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032069.pdf [firstpage_image] =>[orig_patent_app_number] => 10635380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74701 [patent_doc_number] => 07750140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Ghrelin binding nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/522582 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 64 [patent_no_of_words] => 16000 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750140.pdf [firstpage_image] =>[orig_patent_app_number] => 10522582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355097 [patent_doc_number] => 20040048824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Antisense modulation of fibroblast growth factor receptor 3 expression' [patent_app_type] => new [patent_app_number] => 10/630401 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26239 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048824.pdf [firstpage_image] =>[orig_patent_app_number] => 10630401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206350 [patent_doc_number] => 20050043256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Antisense modulation of stearoyl-CoA desaturase expression' [patent_app_type] => utility [patent_app_number] => 10/619253 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34986 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043256.pdf [firstpage_image] =>[orig_patent_app_number] => 10619253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050685 [patent_doc_number] => 20050186572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Polymerase extension at 3\' terminus of PNA-DNA chimera' [patent_app_type] => utility [patent_app_number] => 10/618077 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12915 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186572.pdf [firstpage_image] =>[orig_patent_app_number] => 10618077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465375 [patent_doc_number] => 20040101821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Antiviral antisense therapy' [patent_app_type] => new [patent_app_number] => 10/296262 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8625 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101821.pdf [firstpage_image] =>[orig_patent_app_number] => 10296262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395372 [patent_doc_number] => 20040022727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Aptamer-toxin molecules and methods for using same' [patent_app_type] => new [patent_app_number] => 10/600007 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12996 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022727.pdf [firstpage_image] =>[orig_patent_app_number] => 10600007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725527 [patent_doc_number] => 20030207839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Antisense modulation of Jagged 2 expression' [patent_app_type] => new [patent_app_number] => 10/461668 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25514 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207839.pdf [firstpage_image] =>[orig_patent_app_number] => 10461668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395228 [patent_doc_number] => 20040018181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'MUC1 interference RNA compositions and methods derived therefrom' [patent_app_type] => new [patent_app_number] => 10/447839 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23058 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018181.pdf [firstpage_image] =>[orig_patent_app_number] => 10447839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774246 [patent_doc_number] => 08119610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Method for efficient RNA interference in mammalian cells' [patent_app_type] => utility [patent_app_number] => 10/448612 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 9652 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119610.pdf [firstpage_image] =>[orig_patent_app_number] => 10448612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 473175 [patent_doc_number] => 07230094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Neutral sphingomyelinase antisense ribozyme and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/446519 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11396 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230094.pdf [firstpage_image] =>[orig_patent_app_number] => 10446519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470281 [patent_doc_number] => 20040121353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Modulation of TCPTP signal transduction by RNA interference' [patent_app_type] => new [patent_app_number] => 10/444926 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23721 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121353.pdf [firstpage_image] =>[orig_patent_app_number] => 10444926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317737 [patent_doc_number] => 20040224405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'siRNA induced systemic gene silencing in mammalian systems' [patent_app_type] => new [patent_app_number] => 10/431027 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19905 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224405.pdf [firstpage_image] =>[orig_patent_app_number] => 10431027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367374 [patent_doc_number] => 20040006035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Nucleic acid mediated disruption of HIV fusogenic peptide interactions' [patent_app_type] => new [patent_app_number] => 10/420194 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38098 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006035.pdf [firstpage_image] =>[orig_patent_app_number] => 10420194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865133 [patent_doc_number] => 20030190659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Antisense IAP nucleobase oligomers and uses thereof' [patent_app_type] => new [patent_app_number] => 10/400382 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 22023 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190659.pdf [firstpage_image] =>[orig_patent_app_number] => 10400382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678902 [patent_doc_number] => 20030229043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => new [patent_app_number] => 10/396300 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17386 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229043.pdf [firstpage_image] =>[orig_patent_app_number] => 10396300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805008 [patent_doc_number] => 20030232402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'PNA oligomers, oligomer sets, methods and kits pertaining to the detection of Bacillus anthracis' [patent_app_type] => new [patent_app_number] => 10/393855 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12486 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232402.pdf [firstpage_image] =>[orig_patent_app_number] => 10393855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216814 [patent_doc_number] => 07611723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue' [patent_app_type] => utility [patent_app_number] => 10/507692 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13042 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611723.pdf [firstpage_image] =>[orig_patent_app_number] => 10507692 [rel_patent_id] =>[rel_patent_doc_number] =>)